KRAS and cancer: Consistent with prior findings, KRAS G12C mutations were less frequent in Asian and Black patients compared to White patients in NSCLC, but not other cancers (Fig. 2).28 Other hotspot KRAS mutations affecting amino acid glycine 12 including G12A, G12D, G12F, and G12V were less frequent in Asian and Black patients in NSCLC.